The results suggest that CLDN18 can be reliably detected in patient tumor samples regardless of the collection method or site using the VENTANA CLDN18 (43-14A) RxDx Assay (for Investigational Use Only; VMSI/Roche). Here, CLDN18 is linked to neoplasm.